Pathogenic bovine enterovirus, vaccines, and diagnostic methods

Details for Australian Patent Application No. 2004298530 (hide)

Owner Novartis AG

Inventors Keil, Daniel J.; Anderson, Gary A.; Flakus, Robert J.

Agent Davies Collison Cave

Pub. Number AU-A-2004298530

PCT Pub. Number WO2005/059122

Priority 60/529,349 12.12.03 US

Filing date 10 December 2004

Wipo publication date 30 June 2005

International Classifications

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

A61K 39/125 (2006.01) Medicinal preparations containing antigens or antibodies - Picornaviridae, e.g. calicivirus

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/059122 Priority application(s): WO2005/059122

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004298531-Rotating joint for the mutual connection of two shaft ends in particular in the drivetrain of a motor vehicle

2004298527-RNAi potency prediction method